IRIS
CAPORALI, ROBERTO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 10.962
AS - Asia 9.180
EU - Europa 6.602
SA - Sud America 1.227
AF - Africa 289
OC - Oceania 19
Continente sconosciuto - Info sul continente non disponibili 4
Totale 28.283
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 10.728
CN - Cina 4.601
SG - Singapore 1.931
IE - Irlanda 1.579
HK - Hong Kong 971
BR - Brasile 954
UA - Ucraina 913
FI - Finlandia 838
VN - Vietnam 832
DE - Germania 750
RU - Federazione Russa 721
SE - Svezia 452
FR - Francia 418
IT - Italia 342
GB - Regno Unito 290
IN - India 181
ZA - Sudafrica 152
CA - Canada 137
AR - Argentina 97
BD - Bangladesh 89
IQ - Iraq 83
TR - Turchia 74
JP - Giappone 69
MX - Messico 47
ID - Indonesia 46
SA - Arabia Saudita 45
PL - Polonia 44
AT - Austria 43
CO - Colombia 41
PK - Pakistan 41
EC - Ecuador 36
NL - Olanda 33
ES - Italia 32
VE - Venezuela 32
BE - Belgio 28
CZ - Repubblica Ceca 28
MA - Marocco 26
PH - Filippine 25
MY - Malesia 24
CL - Cile 21
TN - Tunisia 20
EG - Egitto 17
UZ - Uzbekistan 17
IL - Israele 15
AU - Australia 14
IR - Iran 14
LT - Lituania 14
UY - Uruguay 14
JO - Giordania 13
OM - Oman 13
DO - Repubblica Dominicana 12
KE - Kenya 12
SN - Senegal 12
AE - Emirati Arabi Uniti 11
ET - Etiopia 11
NP - Nepal 11
PY - Paraguay 11
PE - Perù 10
HU - Ungheria 9
SY - Repubblica araba siriana 9
AZ - Azerbaigian 8
BO - Bolivia 8
CR - Costa Rica 8
KG - Kirghizistan 8
RO - Romania 8
AL - Albania 7
DZ - Algeria 7
KZ - Kazakistan 7
MU - Mauritius 7
PA - Panama 7
KR - Corea 6
LV - Lettonia 6
GR - Grecia 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
PS - Palestinian Territory 5
TT - Trinidad e Tobago 5
BA - Bosnia-Erzegovina 4
BG - Bulgaria 4
DK - Danimarca 4
EU - Europa 4
HN - Honduras 4
JM - Giamaica 4
LB - Libano 4
NG - Nigeria 4
NI - Nicaragua 4
PT - Portogallo 4
AO - Angola 3
EE - Estonia 3
GY - Guiana 3
HR - Croazia 3
KW - Kuwait 3
LK - Sri Lanka 3
MM - Myanmar 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
TH - Thailandia 3
AM - Armenia 2
BW - Botswana 2
BY - Bielorussia 2
Totale 28.241
Salva come PNG Salva come JPEG
Città #
Dublin 1.576
Chandler 1.470
Jacksonville 1.280
Nanjing 1.066
Hong Kong 954
San Jose 946
Singapore 945
Ashburn 941
Dallas 706
Beijing 638
Boardman 481
Nanchang 426
Princeton 359
Lawrence 327
Wilmington 320
Changsha 310
Shenyang 308
Lauterbourg 306
Hebei 304
Ho Chi Minh City 295
Los Angeles 275
Helsinki 271
Medford 245
Jiaxing 231
Hanoi 194
Hangzhou 176
Tianjin 175
Ann Arbor 161
Munich 150
New York 138
Johannesburg 129
Moscow 127
Redondo Beach 124
Shanghai 114
Buffalo 111
Milan 99
São Paulo 92
Woodbridge 81
Pavia 68
Norwalk 65
Orem 57
Tokyo 57
Toronto 55
Da Nang 54
Seattle 50
Turku 50
Verona 48
Brooklyn 44
Santa Clara 41
Chicago 39
Warsaw 38
Fairfield 35
Haiphong 35
Chennai 34
Falkenstein 34
Montreal 34
London 33
Houston 32
San Francisco 31
Boston 28
Brussels 28
The Dalles 28
Frankfurt am Main 27
Vienna 27
Atlanta 26
Guangzhou 26
Jinan 25
Rio de Janeiro 25
Ankara 24
Baghdad 24
Council Bluffs 24
Stockholm 24
Zhengzhou 24
Phoenix 23
Brasília 22
Porto Alegre 22
Denver 21
Washington 21
Kunming 20
Poplar 20
Amsterdam 19
Belo Horizonte 19
Brno 19
Manchester 19
Ningbo 19
Nuremberg 19
Des Moines 18
Jeddah 18
Columbus 17
Secaucus 17
Pune 16
Biên Hòa 15
Dhaka 15
Riyadh 15
Auburn Hills 14
Campinas 14
Lahore 14
Orange 14
Taizhou 14
Tashkent 14
Totale 18.623
Salva come PNG Salva come JPEG
Nome #
Anterior chest wall arthritis and osteitis associated with Sneddon-Wilkinson disease 168
-238 and +489 TNF-alpha along with TNF-RII gene polymorphisms associate with the diffuse phenotype in patients with Systemic Sclerosis. 151
Assessment of synovitis to predict bone erosions in rheumatoid arthritis 149
BAL cytokine profile in different interstitial lung diseases: a focus on systemic sclerosis 146
Allopurinol Mouthwashes In Methotrexate-induced Stomatitis 145
B cells in rheumatoid arthritis. 145
Anti-neutrophil cytoplasmic antibodies (ANCA) ( Review ) [Anticorpi anticitoplasma dei neutrofili (ANCA)] 138
Prevalence of undiagnosed autoimmune rheumatic diseases in the first trimester of pregnancy. Results of a two steps strategy using a self administered questionnaire and autoantibody testing. 138
In early inflammatory polyarthritis more intensive management according to the 2010 ACR/EULAR criteria leads to higher rates of clinical remission: Comparison of two cohorts treated according to different treat to target protocols 135
A case of adult onset Still's disease treated with infliximab - Reply 135
Disease-related malnutrition in systemic sclerosis: Evidences and implications 134
Cardiovascular comorbidities relate more than others with disease activity in rheumatoid arthritis 133
DMARDS and infections in rheumatoid arthritis 132
Prognostic value of antisynthetase antibodies in patients affected by polymiositis/dermatomyositis with interstitial lung disease 132
Update on the profile of the EUSTAR cohort: an analysis of the EULAR Scleroderma Trials and Research group database. 130
A comparison between nailfold capillaroscopy patterns in adulthood in juvenile and adult-onset systemic sclerosis: A EUSTAR exploratory study 129
Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis. 127
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus. 127
Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins 126
Cytokine profile of bronchoalveolar lavage in systemic sclerosis with interstitial lung disease: comparison with usual interstitial pneumonia 125
Anti-citrullinated protein antibodies and high levels of rheumatoid factor are associated with systemic bone loss in patients with early untreated rheumatoid arthritis 123
Analysis of the apolipoprotein(a) size polymorphism in patients with systemic lupus erythematosus 123
20 years of experience with tumour necrosis factor inhibitors: what have we learned? 123
Diagnostic value of procalcitonin measurement in febrile patients with systemic autoimmune diseases 122
Shrinking lung syndrome in sistemic sclerosis 122
Proliferation characteristics and polyploidization of cultured myofibroblasts from a patient with fibroblastic rheumatism 121
Microcytic anemia in rheumatoid arthritis. Relationship with activity and duration of the disease and iron status. 121
A gender gap in primary and secondary heart dysfunctions in systemic sclerosis: A EUSTAR prospective study 121
Analysis of the apoliporotein(a) size polymorphism in patients with systemic lupus erythematosus 120
B cells in rheumatoid arthritis. 118
Antibodies to cyclic citrullinated peptides in psoriatic arthritis. 117
Analysis of Human Myeloma Cell-population Kinetics 117
Soluble HLA-G in pregnancies complicated by autoimmune rheumatic diseases 117
Serious infections during anti-TNFalpha treatment in rheumatoid arthritis patients 116
TNFalpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunological effects. 115
Long-term Outcome of Children Born to Women with Autoimmune Rheumatic Diseases: A Multicentre, Nationwide Study on 299 Randomly Selected Individuals 115
Interessamento cutaneo nella dermatomiosite 114
Anticyclic citrullinated peptide antibodies as markers of erosive arthritis in antisynthetase syndrome. 114
Diffuse skin reaction after changing the etanercept formulation 114
CCL21 expression pattern of human secondary lymphoid organ stroma is conserved in inflammatory lesions with lymphoid neogenesis 114
Analysis of pharmacologic and nonpharmacologic prescription patterns of general practitioners and specialists in the AMICA study. 114
Serum Jo-1 Autoantibody and Isolated Arthritis in the Antisynthetase Syndrome: Review of the Literature and Report of the Experience of AENEAS Collaborative Group 112
Mature antigen-experienced helper T cells synthesize and secrete the B cell chemoattractant CXCL13 in the inflammatory environment of rheumatoid joint 112
Treatment of rheumatoid arthritis with anti-TNF-alpha agents: A reappraisal 111
Influenza may influence rheumatoid arthritis 111
Association between anti-dsDNA titre increase and thymoma relapse 110
Systemic vasculitis and pregnancy: A multicenter study on maternal and neonatal outcome of 65 prospectively followed pregnancies 110
Autoantibodies to heterogeneous nuclear ribonucleoproteins. 110
Aging in Primary Systemic Vasculitis: Implications for Diagnosis, Clinical Manifestations, and Management 110
Ultrasonographic and MRI characterisation of the palindromic phase of rheumatoid arthritis 109
Life-threatening onset of systemic vasculitis requiring intensive care unit admission: a case series 109
Clinical features of ANCA-positive systemic lupus erythematosus: report of two cases. 109
[TNF-alpha inhibition in anti-Ro/SSA positive patients with rheumatoid arthritis: clinical and immunologic effects]. 109
Fetal programming and systemic sclerosis 107
Uterine artery Doppler velocimetry and obstetric outcomes in connective tissue diseases diagnosed during the first trimester of pregnancy. 106
A Seasonal Pattern In the Onset of Polymyalgia Rheumatica 105
[New classification criteria for rheumatoid arthritis]. 104
Biosimilars: Lights and shadows in rheumatology 104
Efficacy and safety of anti-TNF agents in the Lombardy Rheumatoid Arthritis Network (LORHEN) 104
Systemic sclerosis in aquaporin-4 antibody-positive longitudinally extensive transverse myelitis 104
Structural features of two monoclonal cryocrystalglobulins causing a rheumatic syndrome with vasculitis. 103
Anti-Ro(SS-A) 52 kDa and 60 kDa specificities in undifferentiated connective tissue disease 103
Connective tissue diseases and autoimmune thyroid disorders in the first trimester of pregnancy 103
“Disease knowledge index” and perspectives on reproductive issues: A nationwide study on 398 women with autoimmune rheumatic diseases 103
Prevalence of COVID infections in a population of rheumatic patients from Lombardy and Marche treated with biological drugs or small molecules: A multicentre retrospective study 103
Inflammatory myopathy in a patient with cutaneous findings of pityriasis rubra pilaris: a case of wong's dermatomyositis 103
Systematic microanatomical analysis of CXCL13 and CCL21 in situ production and progressive lymphoid organization in rheumatoid synovitis 102
Anterior chest wall arthritis and osteitis associated with Sneddon-Wilkinson disease 102
Cyclophosphamide plus granulocyte colony stimulating factor (G-CSF) is more 102
The effect of newly diagnosed undifferentiated connective tissue disease on pregnancy outcome 102
Subclinical remodelling of draining lymph node structure in early and established rheumatoid arthritis assessed by power Doppler ultrasonography 101
Prednisone plus Methotrexate for polymyalgia rheumatica. A randomized, double blind, placebo-controlled trial. 101
Role of chemokines and chemokine receptors in regulating specific leukocyte trafficking in the immune/inflammatory response 101
Spondiliti e spondilodisciti batteriche. 100
Autoantibody profile in rheumatoid arthritis during long-term infliximab treatment. 100
Multilevel examination of minor salivary gland biopsy for Sjogren’s syndrome significantly improves diagnostic performance of AECG classification criteria 100
Hematological Abnormalities Associated With Anticardiolipin Antibodies 100
Undifferentiated connective tissue diseases and adverse pregnancy outcomes. An undervalued association? 100
Anti-TNFalpha therapy in a cohort of rheumatoid arthritis patients: Clinical outcomes 100
Association between age at disease onset of anti-neutrophil cytoplasmic antibody-associated vasculitis and clinical presentation and short-term outcomes 100
Anti-neutrophil cytoplasmic antibody specificity determines a different clinical subset in granulomatosis with polyangiitis 100
Autoimmunity in thrombotic thrombocytopenic purpura 99
Characterization of immunoglobulin variable regions of two human pathogenic monoclonal cryocrystalglobulins 99
Role of chemokines in the pathogenesis of chronic synovitis during rheumatoid arthritis 98
Diffuse skin reaction after changing the etanercept formulation. Clin Exp Rheumatol. 98
Biomarkers and prognostic stratification in psoriatic arthritis. 98
Autoantibodies to RNA-polymerases in Italian patients with systemic sclerosis 98
The impact of unrecognized autoimmune rheumatic diseases on the incidence of preeclampsia and fetal growth restriction: A longitudinal cohort study 98
Risk of acute arterial and venous thromboembolic events in Eosinophilic Granulomatosis with Polyangiitis (Churg-Strauss syndrome) 98
null 97
Tumour necrosis factor antagonist therapy and cancer development: Analysis of the LORHEN registry 97
Impaired diastolic function in active rheumathoid arthritis. Relationship with disease duration. 96
Prevalence and significance of previously undiagnosed rheumatic diseases in pregnancy 96
Early, incomplete, or preclinical autoimmune systemic rheumatic diseases and pregnancy outcome 96
Iron Status In Stills Disease 95
Oral low-dose glucocorticoids should be included in any recommendation for the use of non-biologic and biologic disease-modifying antirheumatic drugs in the treatment of rheumatoid arthritis 95
The 158VV Fcgamma receptor 3A genotype is associated with response to rituximab in rheumatoid arthritis: results of an Italian multicentre study. 95
Rheumatoid arthritis in beta-thalassaemia trait 95
Recommendations for infectious disease screening in migrants to Western Europe with inflammatory arthropathies before starting biologic agents. Results from a multidisciplinary task force of four European societies (SIR, SER, SIMET, SEMTSI) facing the largest impact of the flow of migrants today 95
Glucocorticoids in rheumatoid arthritis 95
Totale 11.249
Salva come PNG Salva come JPEG
Categoria #
all - tutte 122.477
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 122.477
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021608 0 0 0 0 0 0 0 0 0 305 234 69
2021/20221.349 31 6 32 14 18 38 44 99 66 20 207 774
2022/20234.426 532 295 37 266 465 466 2 260 1.875 33 116 79
2023/20241.517 169 339 63 115 156 381 16 98 10 49 47 74
2024/20254.179 100 371 96 114 50 175 159 312 1.032 131 458 1.181
2025/20269.092 784 706 1.184 1.017 1.096 404 2.051 419 855 576 0 0
Totale 28.797